menu
    • menu

    Company profile for OrsoBio

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    OrsoBio is a clinical-stage biopharmaceutical company developing first-in-class therapies to address the underlying causes of organ dysfunction in patients with severe metabolic disorders. Our dedicated, highly skilled, and cohesive team of physicians and scientists bring decades of clinical and drug development experience, from academia and industry, that serves as the foundation of our company.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    OrsoBioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Palo Alto, CA
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://orsobio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/orsobio/about/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/OrsoBio

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Orsobio To Showcase Mitochondrial Protonophore Portfolio
    Orsobio To Showcase Mitochondrial Protonophore Portfolio

    04 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251104574653/en/OrsoBio-to-Present-Clinical-and-Preclinical-Data-on-Mitochondrial-Protonophore-Portfolio-for-Obesity-at-ObesityWeek-2025

    BUSINESSWIRE
    04 Nov 2025
    Share Share
    OrsoBio Shares Preclinical Obesity Data at ADA Meeting
    OrsoBio Shares Preclinical Obesity Data at ADA Meeting

    20 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250620799848/en/OrsoBio-to-Present-Preclinical-Data-on-Mitochondrial-Protonophore-Portfolio-in-Models-of-Obesity-at-the-American-Diabetes-Associations-85th-Scientific-Sessions

    BUSINESSWIRE
    20 Jun 2025
    Share Share
    OrsoBio Announces Data on Novel Approach fo Metabolic Dysfunction
    OrsoBio Announces Data on Novel Approach fo Metabolic Dysfunction

    15 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241015543174/en

    BUSINESSWIRE
    15 Oct 2024
    Share Share
    OrsoBio Raises $67M For Mitochondrial Protonophore Obesity Portfolio
    OrsoBio Raises $67M For Mitochondrial Protonophore Obesity Portfolio

    06 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240906799297/en

    BUSINESSWIRE
    06 Sep 2024
    Share Share
    OrsoBio Presents Phase 1 and Preclinical Data at ADA 84th Sessions
    OrsoBio Presents Phase 1 and Preclinical Data at ADA 84th Sessions

    21 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240621611137/en

    BUSINESSWIRE
    21 Jun 2024
    Share Share
    Lilly backs OrsoBio's $60M Series A for PhII trials in obesity and NASH
    Lilly backs OrsoBio's $60M Series A for PhII trials in obesity and NASH

    08 Nov 2023

    // Kyle LaHucik ENDPTS

    https://endpts.com/lilly-backs-orsobios-60m-series-a-for-phii-trials-in-obesity-and-nash/

    Kyle LaHucik ENDPTS
    08 Nov 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search